The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...

For many Hispanic patients and families, that is where the gap between need and treatment can begin. Astellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, ...